share_log

Clearmind Medicine | EFFECT: Others

SEC announcement ·  Mar 25 18:03
Summary by Futu AI
Clearmind Medicine Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on March 22, 2024. The notice, identified by Accession Number 0001213900-24-024410 and Submission Type POS AM, signifies that the company's filing has been formally accepted by the SEC. The effectiveness of the filing, associated with File Number 333-276913, is a critical step in the regulatory process for Clearmind Medicine Inc.
Clearmind Medicine Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on March 22, 2024. The notice, identified by Accession Number 0001213900-24-024410 and Submission Type POS AM, signifies that the company's filing has been formally accepted by the SEC. The effectiveness of the filing, associated with File Number 333-276913, is a critical step in the regulatory process for Clearmind Medicine Inc.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.